Impact of Body Mass Index on Pathological Response after Neoadjuvant Chemotherapy: Results from the I-SPY 2 trial

PURPOSE: Increased body mass index (BMI) has been associated with poor outcomes in women with breast cancer. We evaluated the association between BMI and pathological complete response (pCR) in the I-SPY 2 trial. METHODS: 978 patientsenrolled in the I-SPY 2 trial 3/2010–11/2016 and had a recorded ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Haiyun, Yee, Douglas, Potter, David, Jewett, Patricia, Yau, Christina, Beckwith, Heather, Watson, Allison, O’Grady, Nicholas, Wilson, Amy, Brain, Susie, Pohlmann, Paula, Blaes, Anne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312926/
https://www.ncbi.nlm.nih.gov/pubmed/37397981
http://dx.doi.org/10.21203/rs.3.rs-2588168/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10312926/
https://www.ncbi.nlm.nih.gov/pubmed/37397981
http://dx.doi.org/10.21203/rs.3.rs-2588168/v1

Ejemplares similares